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Figure 2.2 Diagran of the pulsatile flow test apparatus, AP and P 
show the position of the pressure transducers. 
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Figure 2.6 Rowan Ash accelerated fatigue tester 
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Figure 2.9 Closing characteristics of the ISLP size 29 m valves 
in the fatigue tester A and the function tester B 
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Figure 3.1 Key dimensions and geometries for a three leaflet 
pericardial valve. 
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TABLE 3.1 
Rey dimensions for fas size 29 mitral valves 
Valve 
Dimensions nm 
Outside Diameter Do 
Internal Diameter Di 
Height H 
Leaflet height h 
Fbst width w 
Ooaption depth he 
Radii Curvature rc 
Radii Curvature Rr 
Implant Height Hip 
Tissue thickness t 
ISU ISLP RP !!! 
29/28 28.5 28 28 
25 24.5 24 24.5 
20 19 17 16.5 
16 15 12: 5 12.5 
22 2 
432.5 3.5 
20 17.5 15 15 
20 17.5 15 15 
18 17 14 14.5 
0.35 0.55-0.35 0.38 0.5 
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Figure 3.2 A three dimensional plot of the valve leaflet 
sectioned through the vertical centre line OC, defined 
by vertical and horizontal sections at 2.5 mm 
intervals. 
31 
Figure 3.3 Photographs of the size 29 mm pericardial valves. a1 
Ionescu-Shiley Standard (ISU), b1 Ionescu-Shiley low 
profile (ISLP), cl Hancock pericardial (HP), dl Mitral 
Medical (MM) 
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Figure 3.4 The mean pressure difference plotted against RMS 
forward flow for size 29 mm mitral and size 23 cam 
aortic valves. " indicates averge taken over the 
pressure-flow interval and A indicates the average 
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Figure 3.6 Energy losses across the pericardial valves during 
forward flow (open) and during regurgitation (closing 
and closed). 
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Figure 3.7 The closed position of the Ionescu--Shiley standard 
valve (ISU) above, and the Ionescu-Shiley low profile 
valve (ISLP) below, under 100 mn back pressure in the 
pulse duplicator. 
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HP 
MM 
The geometries of the open valve leaflets in the base 
of the leaflet close to the edge of the stent (shown 
by a section through the leaflet centre line OC). 
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Figure 3.9 Results of the accelerated fatigue tests on the size 
29 mn pericardial valves. 
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Figure 3.10 Four failed Ionescu-Shiley valves after the fatigue 
tests. 
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39 
Figure 3.11 Leaflets from a failed Ionescu-Shiley low profile valve 
(1) and a failed Hancock pericardial valve (5) 
trans i lluninated and showing wear and abrasion along 
the edge of the cloth-covered frame on the inflow 
surface 

40 
Figure 3.12 One failed Ionescu-Shiley standard valve after the 
fatigue tests 

41 
Figure 3.13 Three failed Hancock pericardial valves after the 
fatigue tests. 

42 
Figure 3.14 Two failed Mitral Medical valves after the fatigue 
tests 

43 
Figure 4.1 Photographs of the cast of a bovine heart showing the 
anterior surface and position of the two ligaments 
(above) and the posterior surface and posterior 
descending artery (below). 

44 
Figure 4.2 Bovine pericardial membrane dissected down the 
posterior surface, opened out flat and trans illuminated 
looking at the epipericardial surface 
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Figure 4.3 A frame of reference for the pericardial membrane with 
the position of the thickness measurements. 
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TABLE 4.1 
Average tissue thickness in ten sizes 
Position ftan thickness t lso 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
0.41 t 0.07 inn 
0.42} 0.07mn 
0.5 t 0.08 inn 
0.35 t 0.05 mm 
0.31 t0.05mm 
0.32 t 0.09 mm 
0.32t0.04mm 
0.3 t0.05mm 
0.26 t 0.03 mm 
0.49 t 0.09 mm 
0.47 t 0.11 mm 
0.55t0.14nm 
Position Mean thickness t LSD 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
0.58 t 0.09 mn 
0.55ý0.13mn 
0.65 t 0.1 mn 
0.37 ý 0.05 mm 
0.33 t 0.03 mm 
0.28 f 0.05 mn 
0.35 t 0.04 mm 
6.35f0.07mn 
0.33 t 0.05 mm 
0.36t0.04mn 
0.45 t 0.04 mm 
0.34 t 0.05 inn 
0.31 0.04 mm 
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Figure 4.4 Polarised light micrograph of the mesothelial surface 
of the pericardial membrane (x 100) 

48 
Figure 4.5 A diagram of the nenbrane showing the average 
orientation of the fibrils (top) and the areas of 
uniform thickness which were possible sites for 
leaflet manufacture (below). 
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Figure 4.6a Force extension curves for fresh tissue from sac G 
showing the conditioned fifth cycle, first load points 
and extension to ultimate failure for each strip. 
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Figure 4.6b Force extension curves for fresh tissue from sac H 
showing the conditioned fifth cycle, first load points 
and extension to the ultimate failure for each strip. 
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Figure 4.6c Force extension curves for fresh tissue from sac J 
Showing the conditioned fifth cycle, first loadpoints 
and extension to ultimate failure for each strip. 
TABLE 4.2 
Fresh tissue specimens 
Sac Average thickness Specimen First load 
ma Number extension ratio 
on the conditioned 
curve 
G 0.33 1 1.16 
2 1.17 
3 1.17 
4 1.06 
5 1.07 
6 1.09 
H 0.33 1 1.14 
2 1.14 
3 1.17 
4 1.02 
5 1.06 
6 1.08 
J 0.34 1 1.13 
2 1.12 
3 1.10 
4 1.12 
5 1.08 
6 1.08 
52 
53 
20 
2,0 1,75 1,50 1 , 
25 
EXTENSION RATIO 
45 
t0 
05 
10 
1,50 1ý, 5J 
EXTENSION RATIO 
ýl 
O 
cý 
m 
z 
Figure 4.7a Force extension curves for fixed tissue fran sac D 
showing the conditioned fifth cycle and extension to 
ultimate failure for each strip. 
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Figure 4.7b Repeat test for 4.7a using sac E. 
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Figure 4.7c Repeat test for 4.7a using sac F. 
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Sac reference 
D 
E 
F 
TABIE 4.3 
Properties of the fixed tissue 
First load Thickness 
extension ratio for t 
the conditioned tissue 
1.02 to 1.07 
1.02 to 1.05 
1.02 to 1.04 
0.4 
0.36 
0.42 
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Figure 4.8 Absorbance spectra for 0.25% Sigma and 0.25% Agar Aids 
(AA) glutaraldehyde. 
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TABLE 4.4 
Absorbance of five solutions of glutaraldehyde 
(concentration 0.25%) 
Solution Absorbance Absorbance 
235 rm 280 rin 
Technical 1.5 0.24 
Agar Aids 0.08 0.20 
Sigma 0.15 0.22 
Distilled Technical 0.25 0.24 
Filtered Technical 0.1 0.24 
TABLE 4.5 
Concentration Absorbance at 280 na 
Sigma Distilled Technical 
0.5 percent 0.4 0.45 
0.25 percent 0.22 0.24 
0.125 percent 0.11 0.12 
0.06 percent 0.06 0.06 
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Figure 4.9 Absorbance of dilute solution of Sigma (above) and 
technical distilled glutaraldehyde (below) at 235 nM, 
after varying time intervals. 
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Figure 4.10 Absorbance of dilute solutions of glutaraldehyde at 
235 nM at varying time intervals after tissue has been 
added. 
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Figure 4.11 Variation in tissue shrinkage temperature with 
fixation time for fixation with 0.25% and 0.5% 
glutaraldehyde. 
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Figure 4.12 Stratographic analysis of the shrinkage temperature of 
two pieces of tissue fixed with 0.25% glutaraldehyde. 
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a b 
d 
inner 
frame 
wire 
C 
Figure 5.1 Design option 1 for the valve frames. 
a] vertical section through the frame in the base of the 
scallop. 
b] vertical section through the post. 
cl Radial view on the post. 
d] Horizontal section through the post. 
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noý I 
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Figure 5.2 Design option 2 for the valve frames. 
b 
d 
a] vertical section through the frames in the base of the 
scallop. 
b] Vertical section through the post. 
C) Radial view on the post. 
d] Horizontal section through the post. 
outer N M. __ 
inner 5 
sleeve fra 
outer 
sleeve 
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C 
Figure 5.3 Design option 3 for the valve frames. 
b 
d 
i 
t 
a] Vertical section through the frames in the base of the 
scallop. 
b] vertical section through the post. 
c] Radial view on the post. 
d] Horizontal section through the post. 
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ring 
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Figure 5.4 Design option 4 for the valve frames. 
a] Vertical section through the frames in the base of the 
scallop. 
b] Vertical section through the post. 
C] Radial view on the post. 
d] Horizontal section through the post. 
outer ý-sleeve 
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Figure 5.5 Design option 5 for the valve frames. 
a] vertical section through the frames in the base of the 
scallop. 
b] vertical section through the post. 
c] Radial view on the post. 
d] Horizontal section through the post. 
-ss 
a 
C 
Figure 5.6 Leaflet geometry A 
a] Vertical section through 
leaflet. 
b] vertical sections through 
c] Radial view on the post. 
d] Projection of the leaflet 
b 
0 
"E ý\_ýýý 
C 
d 
the centre line OEC of 
the closed leaflets. 
8 
the 
showing the coaption area. 
69 
. 11 
a 
/ 
ý 
--0 
c 
Figure 5.7 Leaflet geometry B 
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d 
a] vertical section through the centre line of the 
leaflet OEC. 
b] Vertical sections through the closed leaflet. 
C] Radial view on the post. 
d] projection of the leaflet showing the increased 
coaption area. 
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Figure 5.8 Leaflet geanetry C 
a] Vertical section through the centre line of the 
leaflet OEC. 
b] vertical section through the closed leaflet. 
c] Radial view on the post. 
d] Horizontal sections through the closed leaflet. 
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Figure 5.9 Leaflet geometry D. 
a) Vertical section through the centre line of the 
leaflet OE. 
b] vertical sections through the closed leaflet. 
c] Radial view on the post. 
d] Horizontal sections through the closed leaflets. 
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Figure 5.10 Vertical section through a closed leaflet showing the 
extension of the tissue in a spherical leaflet. 
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Figure 6.1 Photograph of the inner and outer frame 
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Figure 6.2 Diagram showing the position (above) and dimensions of 
the pin studs and washers. 
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Figure 6.3 Force extension graphs for tissue fixed as a flat 
Sheet. 
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t 
Figure 6.4 Diagram of the leaflet template. 
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A - ---B1, B2 
Figure 6.5 Detailed shape of the valve inner franes for 
configuration Al, B1, B2, B3. 
B3 
A radial view on the 
post (above) and a radial view on the scallop. 
78 
Figure 6.6 Prototype valve configuration A in the function test 
apparatus showing the open position (above) and the 
unstable closed position (below) 

79 
Figure 6.7 Prototype valve configuration Si in the function test 
apparatus, showing the open position (above), the 
unloaded closed position (centre) and the closed 
position under back pressure (below) 
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ro 
Figure 6.8 A vertical section through the leaflet centre line 
showing the extension of the leaflet under pressure. 
81 
Figure 6.9 Prototype valve configuration B3 in the function test 
apparatus showing the open position (above), the 
unloaded closed position (centre) and the closed 
position under back pressure (below) 

82 
Figure 6.10 Photograph of a size 27 mit mould 
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Figure 6.11 Force extension graphs for tissue fixed on a mould. 
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Figure 6.11 Force extension graphs for tissue fixed on a mould. 
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Figure 6.11 Force extension graphs for tissue fixed on a could. 
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Figure 6.12 Diagran of the leaflet geometries for configurations 
Cl and C2, showing a horizontal section and a vertical 
section-through the leaflets. 
87 
Figure 6.13 Prototype valve configuration C in the function test 
apparatus showing the open position (above), the 
unloaded closed position (centre) and the closed 
position under a back pressure (below) 

88 
Figure 6.14 Prototype valve configuration Dl in the function test 
apparatus, showing a] the open position, b] the 
unloaded closed position, cl the closed position under 
pressure, and d] the closed position under pressure 
(side view) 

89 
Figure 6.15 Prototype valve configuration D2 in the function test 
apparatus showing a) the open position, b) the closed 
unloaded position, c) the closed position under back 
pressure, and d) the closed position under back 
pressure (side view) 
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Figure 7.1 A cloth-covered outer frame 

91 
Figure 7.2 A pericardial covered inner frame 

5001 
400 
3Cn 
ý 
V 
c 
0 
ý2C0-; 
1CO4 
F 
I 
2Z1cloth27.2 
cover 
-r10 
H 
b. 
d 
C 
d 
A 
27.3 27.4 27.5 
acetal pericardial 
cover 
Figure 7.3 Fatigue test results for prototype valves with 
different frame coverings. 
93 
Figure 7.4 Failed valves 27.1 (above) and 27.2 (below) with 
cloth-covered frames after fatigue tests 

94 
Figure 7.5 Transilluminated leaflets taken from valve 27.1 with a 
cloth-covered frame (above) and valve 27.4 with a 
pericardial-covered frame (below) 

95 
Figure 7.6 Valves 27.4 (above) and 27.5 (below) with pericardial 
covered frames after 430 million cycles on the fatigue 
tester 
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Vertical Section Through 
Valve Frame 
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let 
smooth surface to 
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Figure 7.7 A vertical section through the valve frames at the 
base of the scallop. 
97 
Figure 7.8 A horizontal section through the leaflets at the top 
of the post showing the space between the leaflets. 
stitch A stitch 8 
Figure 7.9 Two stitch configurations used to seal the leaflets 
above the top of the post. 
99 
Figure 7.10 Closed valves under back pressure in the function test 
apparatus without stitches at the top of the posts 
(above) and with stitches at the top of the posts 
(below) 
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Figure 7.11 An open valve with stitches at the top of the posts in 
the function test apparatus 
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Figure 7.12 Results of accelerated fatigue tests on two valves 
without stitches, four valves with stitch 
configuration A and six valves with stitch 
configuration B. 
102 
Figure 7.13 Valves 27.6 to 27.9 (a to d) after 440 million cycles 
in the fatigue tester 
ab 
Cd 
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Figure 7.14 Valve 31.1 (above) and valve 31.3 (below) with stitch 
configuration B after 160 and 270 million cycles in the 
fatigue tester 
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Figure 7.15 Three dimensional diagram through the centre line of 
the leaflet. 
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Figure 7.16 Diagram showing the critical dimensions for 
implantation of the valve. 
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TABLE 7.1 
Key dimensions for the valves in m 
11 
Size Key dimensions 
Dout Di Ds H 9imp 
31 Mitral 31.5 25.6 41 22 17 
29 Mitral 29.5 23.6 39 21 16 
27 Mitral 27.5 21.8 37 20 15 
25 Mitral 25.5 19.8 35 19 14 
27 Aortic 27.5 21.8 33 19.5 19 
25 Aortic 25.5 19.8 31 18.5 18 
23 Aortic 23.5 18 29 17.5 17 
21 Aortic 21.5 16 27 16.5 16 
19 Aortic 19.5 14.2 25 15.5 15 
31 Mitral 
29 Mitral 
27 Mitral 
25 Mitral 
he hf Rc wd Sab q 
18 16 13 2 13 28.8 30.5 
17 15 12 2 12 26.7 28.5 
16 14 11 2 11 24.6 26.5 
15 13 10 2 10.3 22.8 24.5 
27 Aortic 16 14 11 1.8 11 24.6 26.5 
25 Aortic 15 13 10 1.8 10.3 22.8 24.5 
23 Aortic 14 12 9 1.8 9.3 20.7 22.5 
21 Aortic 13 11 8 1.8 8.3 18.6 20.5 
19 Aortic 12 10 7 1.8 7.5 16.8 18.5 
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Figure 7.17 Views of a size 27 mn mitral valve showing the outf low 
and inflow aspects of the valve 

108 
Figure 7.18 Views of a size 25mn aortic valve showing the outflow 
and inflow aspects of the valve 

toll 
TABLE 8.1 
Key dimensions for the Glasgow and other pericardial valves 
(dimensions mm) 
Valve implant Internal Sewing Implant overall 
size 29mn Diameter Diameter Di Diameter Ds Height Himp Height H 
mitrals Daut 
Glasgow 29.5 23.6 39 16 21 
ISU 31 25 39 18 20 
ISLP 31 24.5 40 17 19 
HP 29 24 36 14 17 
Mri 29 24.5 41 14.5 16.5 
Size 23mm 
aortic 
Glasgow 23.5 18 29 16.5 17.5 
isu 28/25 19.5 28 16 18.5 
ISLP 26/25 19.5 27 14.5 17 
HP 24 20 28 14 16 
! rM 22.5 19 26 14 15 
Figure 8.1 Views of the valve in the function test apparatus 
showing the synchronised leaflet opening and closure at 
10 ms intervals 
opening 
,, m 10 

111 
Figure 8.2a A size 25 inn valve in the function test apparatus at a 
steady flow of 40 ml s'l with one leaflet closed 
Figure 8.2b A size 25 mn valve in the function test apparatus at a 
steady flow of 40 ml s'1 with one leaflet only 
opening at the free edge 
ýi 
nPX )r I I; 
112 
Figure 8.3 Size 25 mm mitral valve in the function test apparatus 
showing 
a) The open position 
bi The closed unloaded position 
cl The closed position under back pressure 
dJ The closed position under back pressure (side view) 
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Figure 8.4 Mean pressure difference plotted against RMS flow for 
size 25 to 31 am mitral valves and size 19 to 27 mm 
aortic valves. 
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III 
TAUE 8.2 
Variation in the effective orifice area (80A) with flow for 
the size 29 ma mitral and 23 mm aortic valves 
RMS FDA RMS EX)A 
flow ant flow aal 
ml s-1 mi s-1 
100 2.25 196 1.67 
146 2.7 250 1.86 
192 3.03 325 1.97 
285 3.5 346 1.99 
368 3.5 382 1.97 
TAME 8.3 
Canparison of the calculated Mh of the valves with the 
actual orifice area of the valve frame 
Size Position Actual orifice E)DA Ratio 
ma area of frame 
ant aa2 
31 Mitral 5.1 4.0 0.78 
29 Mitral 4.4 3.51 0.79 
27 Mitral 3.7 2.79 0.76 
25 Aortic 3.07 2.6 0.84 
23 Aortic 2.43 1.99 0.81 
21 Aortic 2.01 1.54 0.76 
19 Aortic 1.58 1.29 0.82 
115' 
116 TABLE 8.4 
The variation in the mean pressure difference across 
size 25 mm mitral valves 
YMS Flow Mean pressure 
ml s-1 dtfferrnm 
mugg 
186 3.21 
186 3.07 
184 2.7 
185 3.52 
186 3.28 
186 2.8 
185 3.5 
185 2.78 
183 3.5 
180 3.02 
mean f 1SD 3.14 t 0.31 
81 HV 29 8. MM 29 
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Figure 8.5 The mean pressure difference across the size 29 inn and 
size 23 mm Glasgow valves (GHV) canpared to the 
Hancock pericardial (HP), Mitral medical (MM), Ionescu 
Shiley Low profile (ISLP) and Ionescu Shiley standard 
(ISU) valves. 
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Figure 8.6 Regurgitant volumes for the size 25 mm to 31 mm mitral 
valves and size 19 to 27 nm aortic valves. 
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Figure 8.7 Regurg itant volumes for the size 29 and size 23 Rm 
Glasgow valves (GHV) compared to the Hancock 
Pericardial. (HP) Mitral Medical (MM), Ionescu Shiley 
Low Profile (ISLP) and Ionescu Shiley Standard (ISU) 
valves (ISLP) valves for the five flow conditions A to 
F. 
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Figure 8.8 Energy losses across the Glasgow valves (GHV) (size 29 
and 23 nm) ccmpared to the HP, MM, ISLP and ISU 
pericardial valves for the five flow conditions A to 
11 
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Figure 8.9 Fatigue test results for nine valves manufactured to 
the final specification and seven valves with stitch 
configuration B. 
121 
122 
Figure 8.10 Valve 29.1 failed after 156 million cycles in the 
fatigue tester 
a tt 
123 
Figure 8.11 Valves 29.2 to 29.5 after 440 million cycles in the 
fatigue tester 
al Valve 29.2 
b] Valve 29.3 
cl Valve 29.6 
dl Valve 29.5 
d 
124 
Figure S. 12 Valves 31.1 to 31.6 and valve 29.6 after the fatigue 
tests 
a] Valve 31.1 
b] Valve 31.2 
cl Valve 31.3 
d] Valve 31.4 
e] Valve 31.5 
Q Valve 31.6 
g] Valve 29.6 
a 
d 
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TABLE 8.5 
Comparison of the hydrodynamic function of the valves before and after the fatigue tests 
Valve p Mean pressure Regurgitation ml 
flow difference mmHg closing closed 
ml s-1 before after before after before after 
27.6 192 2.2 2.4 5.9 6.1 0.7 1.1 
27.7 194 2.6 2.1 4.0 5.0 0.8 0.5 
27.8 192 3.4 2.9 5.9 6.6 1.0 0.3 
27.9 190 2.9 2.4 5.1 5.7 0.8 0.1 
29.1 146 1.2 1.8 7.5 8.8 1.2 23.8 F 
29.2 142 1.2 1.3 7.0 6.6 1.1 0.9 
29.3 143 1.0 1.0 5.9 5.3 1.1 0.8 
29.4 141 1.1 - 1.2 7.0 
5.6 0.7 0.4 
29.5 143 1.2 1.1 7.0 6.8 0.5 0.1 
31.1 190 1.3 1.6 7.9 8.3 0.8 0.3 F 
31.2 191 1.2 1.0 7.5 8.4 0.3 4.9 F 
31.3 186 1.0 0.8 7.6 7.8 1.3 1.4 F 
31.4 190 1.2 1.0 7.8 7.8 1.0 0.8 
31.5 193 1.0 1.1 7.9 4.8 1.1 24.5 F 
31.6 186 1.3 1.2 7.3 7.5 0.8 0.5 
29.6 145 1.1 0.9 6.6 7.0 0.8 2.6 F 
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Figure 9.1 Explanted valve 1 
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Figure 9.2 Explanted valve 2 
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Figure 9.3 Explanted valve 3 
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Figure 9.4 Explanted valve 4 
ý 
.ý . r. _ 
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Figure 9.5 Explanted valve 5 
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Figure 9.6 Explanted valve 6 
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Figure 9.7 Explanted valve 7 

133 
Figure 9.8 X-ray film of explanted valves 1 to 7 and a control 
valve prior to implant 

134 
gigwce 9.9 X-ray film of leaflets from explanted valves 1 to 5 and 
valve 7 

TABLE 9.1 
Hydrodynamic function test results on 
implanted I and explanted E valves 
Valve RIMS Mean Pressure 
No. Flow Difference 
ml s-1 nmHg 
80A Regýagitation 
cm2 mi 
Closing Closed 
IEIEIBIE 
1 100 1.2 1.8 1.8 1.5 4.8 5.4 2.9 2.8 
1 180 2.7 4.3 2.2 1.7 4.5 5.5 2.9 2.9 
135 
2 104 1.5 2.0 1.7 1.4 4.8 4.2 2.5 1.7 
2 187 3.3 4.3 2.0 1.7 4.4 4.4 1.9 1.2 
3 102 1.2 2.9 1.9 1.2 4.3 6.7 2.1 1.2 
3 183 3.8 7.1 1.8 1.3 5.2 5.2 2.5 1.3 
4 100 1.5 3.8 1.6 1.0 5.3 4.1 2.1 0 
4 173 3.4 8.3 1.9 1.3 5.4 3.7 2.0 0.3 
5 101 1.5 2.1 1.6 1.4 5.0 4.8 2.7 1.4 
5 182 3.6 4.6 1.9 1.6 5.0 4.6 2.3 1.2 
6 105 1.8 2.6 1.5 1.3 5.0 7.0 2.0 1.9 
6 184 3.9 5.2 1.7 1.5 4.8 6.7 2.0 1.4 
7 100 1.5 2.4 1.6 1.2 5.1 4.4 2.4 1.6 
7 181 3.0 5.4 2.0 1.5 4.7 4.2 3.2 1.0 
136 11 
Figure 9.10 Histological section of a pericardial valve leaflet, a] 
prior to implant, and b) after explant. a] is a 
transverse section through the leaflet and b] a section 
parallel to the surface of the leaflet (Mag x 100) 
haematoxylin and eosin stain) 
a 
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Figure A1.1 Pressure and flow waveforms for a Bjork-Shiley size 29 
mm spherical disc valve in the mitral position, test 
conditions C, showing reference points 1 to 5. 
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Figure Al. 2 Mean pressure difference plotted against RMS forward 
flow for the size 29 nm Bjork-Shiley Tilting Disc 
valve BSS and the ISLP valves " pressure flow, 
a pressure-pressure, 0 flow-flow,   flow-pressure time 
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Figure Al. 3 Mean pressure difference plotted against RMS forward 
flow for the BSS 29 mm mitral valves (above) and the 
BSS 23 mm aortic valve for varying downstrean pressure 
measurement points. Flor the mitral valve 75 mn, 
50 ma and 25 mm downstrean of the valve. 
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Figure A1.4 Flow and differential pressure waveforms showing the 
reference points and reverse flow time intervals. 
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Figure A1.5 Dynaanic regurgitation closing volume for the size `29 
nm BSS valve positioned in the horizontal (h) and 
vertical plane (v) above and with compliance (c) in 
the pump chamber (below). 
Error bars are * 2SD. 
